RYTMONORM 150mg tablets medication leaflet

C01BC03 propafenone • Cardiovascular system | Antiarrhythmics, class I and III | Antiarrhythmics, class Ic

Propafenone is a medication used to treat cardiac arrhythmias, such as atrial fibrillation or ventricular tachycardia. It belongs to the class Ic antiarrhythmics and works by slowing the conduction of electrical impulses in the heart, restoring normal heart rhythm.

The medication is taken orally, usually in tablet form, and should be used as directed by your doctor. It is important to monitor cardiac function during treatment to prevent complications.

Side effects may include dizziness, nausea, constipation, or fatigue. In rare cases, severe adverse effects such as worsening arrhythmias or heart failure may occur, requiring immediate medical attention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as heart or liver diseases, to ensure the safe use of propafenone.

RYTMONORM 150mg tablets MYLAN, propafenone

General data about RYTMONORM 150mg

Substance: propafenone

Date of last drug list: 01-06-2025

Commercial code: W62345001

Concentration: 150mg

Pharmaceutical form: tablets

Quantity: 50

Product type: original

Price: 33.56 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ABBVIE DEUTSCHLAND GMBH&CO. KG - GERMANIA

Holder: MYLAN HEALTHCARE GMBH - GERMANIA

Number: 7093/2014/01

Shelf life: 3 years

Pharmaceutical forms available for propafenone

Concentrations available for propafenone

150mg, 300mg, 35mg/10ml, 70mg/20ml

Other substances similar to propafenone

Compensation lists for RYTMONORM 150mg MYLAN

A - Sublist A with 90% discount from the reference price

Price

Copayment

Patient

33.56 RON

19.17 RON

14.39 RON